On the first day of 2007, Chinese Medical Authority List was publicly announced. President Yan Xijun won the first place on the list due to his excellent leadership to Tasly Group in the aspect of self-innovation, TCM development and international market expansion.
Chinese Pharmaceutical and Economic Paper commented, Mr Yan is, and will be striding forward . Tasly had its own advantages in winning the award. In July 2006, Tasly became one of the experimental enterprises collectively chosen by National Technology Department, State-owned Assets Supervision and Administration Commission and All China Federation of Trade Unions. Tasly s history of development also strongly proved its ability and potentiality. More than 12years ago, Mr. Yan invested 12million RMB to build up the company, which now grows into a pharmaceutical giant in modern TCM area with its total assets over 6.7 billion RMB.Its most successful product; Compound Danshen Dripping Pill enjoys a sales amount of more than 1 billion, which is very rare in domestic pharmaceutical market. Tasly had already become the pioneering force of TCM modernization and internationalization. It also won the approval of American FDA IND Standard.
On one hand, the Group use the major products to expanded market abroad, Compound Danshen Dripping Pill had entered into over 10 countries and regions; on the other, Tasly is seeking international cooperators for strategic investment, in order to join the major medical market by the assistance of the cooperators.
